Why Your Erection Doesn't Last (Even When Desire Is There)

Scientific concepts / discoveries / nature phenomena presented

Erectile dysfunction (ED) and “venous leak”

• Venous leak is presented as a major cause of ED, framed less as primary arterial blockage and more as failure of erectile tissue to function properly due to excess connective tissue/scar.
• The speaker compares this to other organ failures where scar tissue (excess collagen) accumulates, such as:
  • lungs
  • liver
  • heart failure
  • kidney failure

Key mechanistic claim

• Connective tissue accumulation prevents normal tissue expansion.
• Penis expansion normally helps preserve space where veins drain.
• Expansion against surrounding tissue/capsule reduces the subtunical space (the “space” where venous drainage occurs).
• With reduced drainage space, venous blood becomes trapped—described as impaired “blood in, blood out”—worsening erection quality.

Ultrasound assessment of penile scarring

• Ultrasound is described as a way to estimate the amount of scar/connective tissue in the penis.
• Imaging changes are used as indirect tissue-quality markers (e.g., differing gray vs black regions).
• The claim is that successful therapy increases the “good” imaging category.

Treatment strategies for ED (before implants)

The video frames ED care into two broad approaches: symptomatic treatment vs disease modification.

A) Symptomatic treatment (maximize relaxation)

• Pills (medications aimed at erection/relaxation)
• Penile injections of vasodilators
• Subcutaneous bremelanotide (also referenced earlier in relation to orgasm)
• Intracavernosal Botox

B) Disease modification (reduce connective tissue / grow muscle)

• Goal: increase muscle relative to connective tissue (shift the muscle–collagen ratio).
• Therapies mentioned:
  • Shockwave therapy
  • PRP (platelet-rich plasma)

The video claims these may help by promoting regenerative processes, described later as activating mesenchymal stem cells, leading to downstream muscle cells.

Regenerative therapy / shockwave evidence claims

• The speaker describes involvement with the International Society for the Study of Medical Shockwave Therapy (ISMST).
• A cardiology/heart failure example is used to argue for shockwave’s regenerative potential:
  • in heart failure patients with scarred/dead muscle, shockwave is purported to improve muscle contraction capacity and function.

Double-blind placebo-controlled trial design (shockwave)

• Participants were placed behind a curtain to hide active vs sham treatment.
• Noise-reducing headphones helped conceal audible cues.
• The probe was applied to the penis with movement/sound designed to mimic treatment sensations.
• The endpoint validating effect involved before-and-after ultrasound changes, with the claim that:
  • only true shockwave increased favorable imaging changes
  • sham did not

Skepticism and safety/quality concerns about “shockwave” devices

• The speaker argues some marketed “shockwave” devices are not real focused shockwave.
• Distinctions are drawn between:
  • Real focused shockwave (positioned as physician-involved; regulatory distinction discussed)
  • Radio ballistic pressure waves and other radial/acoustic alternatives marketed as shockwave

Core emphasis

• Home devices marketed as shockwave may be ineffective unless they deliver true focused shockwave and meet correct regulatory/clinical standards.
• The video highlights potential fraud/mislabeling, where devices look/sound similar but deliver different energy/waveforms.

PRP controversy

• The speaker notes randomized controlled trials have shown negative results, but claims benefit in their own population using shockwave + PRP, supported by ultrasound before/after comparisons.
• Proposed biology (as stated):
  • PRP may work by activating mesenchymal stem cells, promoting muscle regeneration.

Supplements and evidence critique

• The video emphasizes an evidence-based stance:
  • there is no robust placebo-controlled double-blind data for supplements supporting erections.
• Additional concerns:
  • some supplements may be harmful (including liver injury)
  • some may contain elements (e.g., copper) linked to erectile dysfunction

---

Female sexual dysfunction (expanded “sexual medicine” scope)

Overpsychologizing vs biological contributors

• The video rejects the simplistic claim that sexual dysfunction is “100% psychological.”
• It also states biology can trigger psychological fixation/rumination once symptoms appear.
• Critique: patients told “it’s all in your head” may be harmed if adequate medical evaluation is not performed.

Hormonal contraception and sexual dysfunction (HSDD / low desire)

Central mechanism proposed

• All hormonal birth control is said to substantially increase SHBG (sex hormone-binding globulin).
• Higher SHBG binds sex hormones (especially testosterone), reducing free testosterone available to tissues.

How the video explains variability

• The video claims low testosterone becomes common among users, but sexual dysfunction occurs in a subset due to differences in androgen receptor quality.
• People with “crappy” androgen receptors supposedly need higher testosterone to maintain sexual function.
• An example is given based on a study assessing androgen receptor characteristics in people on Yaz, with and without symptoms.

“Permanent elevation” after stopping contraception (as claimed)

• The video claims SHBG elevation may not fully revert to baseline, leading to a persistent low-testosterone-like state and downstream issues such as:
  • depression
  • fatigue
  • bone/muscle effects
• It also notes a care gap:
  • lack of FDA-approved testosterone therapy and limited routine measurement of testosterone

HSDD treatment options (FDA-approved)

Two products are highlighted as addressing the excitation vs inhibition balance:

• Flibanserin: daily pill for low sexual desire (excitation/inhibition modulation)
• Bremelanotide (Vyleesi): subcutaneous, taken on demand (described as analogous to a “Viagra concept” for timing)

SSRIs and a “double jeopardy” claim

• The video claims people with depression/anxiety (and those taking SSRIs) may be more likely to experience sexual side effects.
• It argues depression is common among young adults, and if depression begins or worsens on contraception, SSRIs may further compound sexual dysfunction.

LARC

• LARC (long-acting reversible contraception) is mentioned as having fewer side effects than hormonal birth control pills (as described in the subtitles).

---

Researchers / sources featured (named)

• Dr. Irwin Goldstein (mentioned as the source of an earlier/embedded clip and referenced for a full episode)